rs151001642
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_138691.3(TMC1):c.1165C>T(p.Arg389Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000136 in 1,613,974 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_138691.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMC1 | NM_138691.3 | c.1165C>T | p.Arg389Ter | stop_gained | 15/24 | ENST00000297784.10 | NP_619636.2 | |
TMC1 | XM_017014256.2 | c.1168C>T | p.Arg390Ter | stop_gained | 12/21 | XP_016869745.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMC1 | ENST00000297784.10 | c.1165C>T | p.Arg389Ter | stop_gained | 15/24 | 1 | NM_138691.3 | ENSP00000297784 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152100Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000676 AC: 17AN: 251356Hom.: 0 AF XY: 0.0000663 AC XY: 9AN XY: 135830
GnomAD4 exome AF: 0.000143 AC: 209AN: 1461756Hom.: 0 Cov.: 31 AF XY: 0.000139 AC XY: 101AN XY: 727184
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152218Hom.: 0 Cov.: 32 AF XY: 0.0000806 AC XY: 6AN XY: 74420
ClinVar
Submissions by phenotype
not provided Pathogenic:4
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Nov 16, 2023 | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 25525159, 15605408, 18259073, 31589614, 25560255, 29533536, 34523024, 33879512, 21917145, 18616530) - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 05, 2024 | This sequence change creates a premature translational stop signal (p.Arg389*) in the TMC1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TMC1 are known to be pathogenic (PMID: 11850618, 22105175). This variant is present in population databases (rs151001642, gnomAD 0.01%). This premature translational stop signal has been observed in individuals with autosomal recessive non-syndromic hearing loss (PMID: 15605408, 18259073, 21917145). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 47856). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jul 23, 2020 | The variant creates a premature nonsense codon, and is therefore predicted to result in the loss of a functional protein. Found in at least one patient with expected phenotype for this gene, and found in general population data at a frequency that is consistent with pathogenicity. - |
Pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jan 17, 2017 | - - |
Autosomal recessive nonsyndromic hearing loss 7 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Clinical Genomics Laboratory, Washington University in St. Louis | Jan 25, 2024 | The TMC1 c.1165C>T (p.Arg389Ter) variant has been reported in 19 individuals affected with autosomal recessive nonsyndromic hearing loss and is reported to segregate with disease in 14 individuals in 4 families (Brownstein Z et al., PMID: 21917145; Hilgert N et al., PMID: 18616530; Meyer CG et al., PMID: 15605408; Nishio SY and Usami SI, PMID: 34523024; Tlili A et al., PMID: 18259073). Of those individuals, seven were compound heterozygous for the variant and a pathogenic or likely pathogenic variant, confirmed in trans (Brownstein Z et al., PMID: 21917145; Meyer CG et al., PMID: 15605408) and 12 individuals were homozygous for the variant (Hilgert N et al., PMID: 18616530; Meyer CG et al., PMID: 15605408; Nishio SY and Usami SI, PMID: 34523024). This variant causes a stop gain, leading to a premature termination codon, which is predicted to lead to nonsense mediated decay. This variant is only observed on 19 out of 282,746 alleles in the general population (gnomAD v.2.1.1), indicating it is not a common variant. This variant has been reported in the ClinVar database as a germline pathogenic variant by five submitters. Based on available information and the ACMG/AMP guidelines for variant interpretation (Richards S et al., PMID: 25741868), this variant is classified as pathogenic. - |
Rare genetic deafness Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Sep 05, 2013 | The Arg389X variant in TMC1 has been reported in several individual with hearing loss (Hilgert 2008, Meyer 2005, Tlili 2008). All of these individuals were eith er homozygous or compound heterozygous and this variant segregated with hearing loss in several families. This nonsense variant leads to a premature termination codon at position 389, which is predicted to lead to a truncated or absent prot ein. In summary, this variant meets our criteria to be classified as pathogenic (http://pcpgm.partners.org/LMM). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at